nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Aseptic necrosis—Methotrexate—esophageal cancer	0.0308	0.0902	CcSEcCtD
Fludrocortisone—Glucose tolerance impaired—Cisplatin—esophageal cancer	0.024	0.0704	CcSEcCtD
Fludrocortisone—Papilloedema—Cisplatin—esophageal cancer	0.0203	0.0596	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—AQP3—esophageal cancer	0.0198	0.0446	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—NR1I2—esophageal cancer	0.0179	0.0403	CbGpPWpGaD
Fludrocortisone—NR3C2—Preimplantation Embryo—SOX2—esophageal cancer	0.0134	0.0301	CbGpPWpGaD
Fludrocortisone—Amcinonide—ANXA1—esophageal cancer	0.0131	0.234	CrCbGaD
Fludrocortisone—NR3C2—bronchus—esophageal cancer	0.0129	0.0819	CbGeAlD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—KRT17—esophageal cancer	0.0127	0.0286	CbGpPWpGaD
Fludrocortisone—NR3C2—smooth muscle tissue—esophageal cancer	0.0126	0.0801	CbGeAlD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—NOS3—esophageal cancer	0.0122	0.0274	CbGpPWpGaD
Fludrocortisone—NR3C2—trachea—esophageal cancer	0.0116	0.0735	CbGeAlD
Fludrocortisone—AR—FOXA1 transcription factor network—XBP1—esophageal cancer	0.0115	0.0258	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RNF6—esophageal cancer	0.0109	0.0245	CbGpPWpGaD
Fludrocortisone—Diabetic—Methotrexate—esophageal cancer	0.0106	0.0312	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—NR1I2—esophageal cancer	0.0105	0.0236	CbGpPWpGaD
Fludrocortisone—Optic neuritis—Cisplatin—esophageal cancer	0.0105	0.0308	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—PRDX1—esophageal cancer	0.0104	0.0234	CbGpPWpGaD
Fludrocortisone—NR3C1—neck—esophageal cancer	0.0103	0.0655	CbGeAlD
Fludrocortisone—NR3C2—digestive system—esophageal cancer	0.00998	0.0633	CbGeAlD
Fludrocortisone—AR—epithelium—esophageal cancer	0.00971	0.0616	CbGeAlD
Fludrocortisone—AR—bronchus—esophageal cancer	0.00957	0.0606	CbGeAlD
Fludrocortisone—Osteonecrosis—Methotrexate—esophageal cancer	0.00953	0.0279	CcSEcCtD
Fludrocortisone—AR—smooth muscle tissue—esophageal cancer	0.00936	0.0593	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SNAI2—esophageal cancer	0.009	0.0202	CbGpPWpGaD
Fludrocortisone—NR3C2—lung—esophageal cancer	0.00833	0.0528	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR1I2—esophageal cancer	0.00831	0.0187	CbGpPWpGaD
Fludrocortisone—Impaired healing—Methotrexate—esophageal cancer	0.00821	0.024	CcSEcCtD
Fludrocortisone—Hirsutism—Capecitabine—esophageal cancer	0.0082	0.024	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00801	0.0235	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—NR1I2—esophageal cancer	0.00798	0.0179	CbGpPWpGaD
Fludrocortisone—Infection—Carboplatin—esophageal cancer	0.00781	0.0229	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PHB—esophageal cancer	0.00781	0.0176	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PRDX1—esophageal cancer	0.00768	0.0173	CbGpPWpGaD
Fludrocortisone—AR—digestive system—esophageal cancer	0.00739	0.0468	CbGeAlD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CRTC1—esophageal cancer	0.00706	0.0159	CbGpPWpGaD
Fludrocortisone—NR3C1—epithelium—esophageal cancer	0.00703	0.0446	CbGeAlD
Fludrocortisone—NR3C1—bronchus—esophageal cancer	0.00693	0.0439	CbGeAlD
Fludrocortisone—NR3C1—smooth muscle tissue—esophageal cancer	0.00678	0.043	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX1—esophageal cancer	0.00675	0.0152	CbGpPWpGaD
Fludrocortisone—Osteoporosis—Methotrexate—esophageal cancer	0.00633	0.0186	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.00633	0.0142	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—esophageal cancer	0.00631	0.0142	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—esophageal cancer	0.00622	0.014	CbGpPWpGaD
Fludrocortisone—NR3C1—trachea—esophageal cancer	0.00622	0.0394	CbGeAlD
Fludrocortisone—AR—lung—esophageal cancer	0.00617	0.0391	CbGeAlD
Fludrocortisone—Fluid retention—Cisplatin—esophageal cancer	0.00614	0.018	CcSEcCtD
Fludrocortisone—Fracture—Methotrexate—esophageal cancer	0.00611	0.0179	CcSEcCtD
Fludrocortisone—Multiple fractures—Methotrexate—esophageal cancer	0.00611	0.0179	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00597	0.0175	CcSEcCtD
Fludrocortisone—Petechiae—Capecitabine—esophageal cancer	0.00579	0.017	CcSEcCtD
Fludrocortisone—NR3C2—lymph node—esophageal cancer	0.0057	0.0361	CbGeAlD
Fludrocortisone—Hydrocortisone—ANXA1—esophageal cancer	0.00553	0.0984	CrCbGaD
Fludrocortisone—Contusion—Capecitabine—esophageal cancer	0.00546	0.016	CcSEcCtD
Fludrocortisone—NR3C1—digestive system—esophageal cancer	0.00535	0.0339	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—esophageal cancer	0.00534	0.012	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00518	0.0152	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—esophageal cancer	0.00512	0.0115	CbGpPWpGaD
Fludrocortisone—Cataract—Capecitabine—esophageal cancer	0.00501	0.0147	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.0049	0.011	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00485	0.0142	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SFN—esophageal cancer	0.00465	0.0105	CbGpPWpGaD
Fludrocortisone—Fluid retention—Capecitabine—esophageal cancer	0.00453	0.0133	CcSEcCtD
Fludrocortisone—NR3C1—lung—esophageal cancer	0.00447	0.0283	CbGeAlD
Fludrocortisone—Oesophagitis—Capecitabine—esophageal cancer	0.00436	0.0128	CcSEcCtD
Fludrocortisone—Petechiae—Methotrexate—esophageal cancer	0.00431	0.0126	CcSEcCtD
Fludrocortisone—Ecchymosis—Capecitabine—esophageal cancer	0.00431	0.0126	CcSEcCtD
Fludrocortisone—Neoplasm—Capecitabine—esophageal cancer	0.00431	0.0126	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—XRCC3—esophageal cancer	0.00428	0.00962	CbGpPWpGaD
Fludrocortisone—AR—lymph node—esophageal cancer	0.00422	0.0268	CbGeAlD
Fludrocortisone—NR3C1—Endoderm Differentiation—SOX2—esophageal cancer	0.00415	0.00933	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ANXA1—esophageal cancer	0.00412	0.0733	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—esophageal cancer	0.00405	0.0091	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Capecitabine—esophageal cancer	0.004	0.0117	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Capecitabine—esophageal cancer	0.00398	0.0117	CcSEcCtD
Fludrocortisone—Pancreatitis—Cisplatin—esophageal cancer	0.00398	0.0117	CcSEcCtD
Fludrocortisone—Sweating increased—Cisplatin—esophageal cancer	0.00395	0.0116	CcSEcCtD
Fludrocortisone—Vascular purpura—Capecitabine—esophageal cancer	0.00387	0.0113	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.00372	0.00836	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00363	0.00816	CbGpPWpGaD
Fludrocortisone—Purpura—Capecitabine—esophageal cancer	0.00359	0.0105	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—SFN—esophageal cancer	0.00346	0.00778	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HIF1A—esophageal cancer	0.00343	0.00772	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CALR—esophageal cancer	0.0034	0.00765	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—KDR—esophageal cancer	0.00328	0.00738	CbGpPWpGaD
Fludrocortisone—Mood swings—Capecitabine—esophageal cancer	0.00328	0.00961	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—esophageal cancer	0.00321	0.0094	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—esophageal cancer	0.00321	0.0094	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00316	0.0071	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00309	0.00696	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NOTCH1—esophageal cancer	0.00309	0.00696	CbGpPWpGaD
Fludrocortisone—NR3C1—lymph node—esophageal cancer	0.00306	0.0194	CbGeAlD
Fludrocortisone—Muscular weakness—Capecitabine—esophageal cancer	0.00305	0.00894	CcSEcCtD
Fludrocortisone—Abdominal distension—Capecitabine—esophageal cancer	0.00301	0.00882	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—CYP26A1—esophageal cancer	0.00298	0.00671	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Methotrexate—esophageal cancer	0.00298	0.00872	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—esophageal cancer	0.00296	0.00868	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—CREBBP—esophageal cancer	0.00296	0.00665	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00292	0.00656	CbGpPWpGaD
Fludrocortisone—Sweating increased—Capecitabine—esophageal cancer	0.00291	0.00854	CcSEcCtD
Fludrocortisone—Erythema—Cisplatin—esophageal cancer	0.00283	0.00828	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.00282	0.00633	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00282	0.00633	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CREBBP—esophageal cancer	0.00281	0.00631	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—RB1—esophageal cancer	0.00279	0.00628	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.00272	0.0061	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Capecitabine—esophageal cancer	0.0027	0.00791	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00266	0.0078	CcSEcCtD
Fludrocortisone—Spironolactone—ABCC2—esophageal cancer	0.00259	0.046	CrCbGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—esophageal cancer	0.00258	0.00579	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—CREBBP—esophageal cancer	0.00255	0.00573	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SMAD4—esophageal cancer	0.00252	0.00566	CbGpPWpGaD
Fludrocortisone—Convulsion—Cisplatin—esophageal cancer	0.00245	0.00718	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—esophageal cancer	0.00244	0.00715	CcSEcCtD
Fludrocortisone—Myalgia—Cisplatin—esophageal cancer	0.00241	0.00705	CcSEcCtD
Fludrocortisone—Haemoglobin—Capecitabine—esophageal cancer	0.00241	0.00705	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.0024	0.00539	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Capecitabine—esophageal cancer	0.00239	0.00702	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—SMAD4—esophageal cancer	0.00237	0.00533	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ANXA1—esophageal cancer	0.00231	0.00519	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Cisplatin—esophageal cancer	0.00231	0.00676	CcSEcCtD
Fludrocortisone—Oedema—Cisplatin—esophageal cancer	0.00231	0.00676	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—esophageal cancer	0.0023	0.00517	CbGpPWpGaD
Fludrocortisone—Infection—Cisplatin—esophageal cancer	0.00229	0.00672	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CASP8—esophageal cancer	0.00229	0.00514	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Cisplatin—esophageal cancer	0.00223	0.00654	CcSEcCtD
Fludrocortisone—Prednisolone—CYP2A6—esophageal cancer	0.00222	0.0395	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00221	0.00497	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00219	0.00492	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Methotrexate—esophageal cancer	0.00218	0.0064	CcSEcCtD
Fludrocortisone—Methyltestosterone—CYP19A1—esophageal cancer	0.00215	0.0382	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00214	0.0048	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.0021	0.00616	CcSEcCtD
Fludrocortisone—Erythema—Capecitabine—esophageal cancer	0.00208	0.00611	CcSEcCtD
Fludrocortisone—Betamethasone—CYP19A1—esophageal cancer	0.00207	0.0368	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.00206	0.00463	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—EP300—esophageal cancer	0.00201	0.00453	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.00201	0.00452	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—esophageal cancer	0.00199	0.00448	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—esophageal cancer	0.00197	0.00443	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SMG6—esophageal cancer	0.00197	0.00442	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.00194	0.00437	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—CREBBP—esophageal cancer	0.00193	0.00435	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NOS2—esophageal cancer	0.00193	0.0343	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—BAX—esophageal cancer	0.00193	0.00434	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00191	0.0043	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—EP300—esophageal cancer	0.00191	0.00429	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—esophageal cancer	0.00189	0.00426	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CYP19A1—esophageal cancer	0.00188	0.00423	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—CREBBP—esophageal cancer	0.00188	0.00422	CbGpPWpGaD
Fludrocortisone—Vertigo—Capecitabine—esophageal cancer	0.00187	0.00549	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00181	0.00408	CbGpPWpGaD
Fludrocortisone—Hypertension—Capecitabine—esophageal cancer	0.0018	0.00527	CcSEcCtD
Fludrocortisone—Progesterone—CYP1B1—esophageal cancer	0.00179	0.0319	CrCbGaD
Fludrocortisone—Haemoglobin—Methotrexate—esophageal cancer	0.00179	0.00525	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—esophageal cancer	0.00178	0.00522	CcSEcCtD
Fludrocortisone—Myalgia—Capecitabine—esophageal cancer	0.00177	0.0052	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—esophageal cancer	0.00176	0.00395	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00175	0.00394	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NOTCH1—esophageal cancer	0.00175	0.00393	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.00174	0.00392	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.00174	0.00392	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.00174	0.0039	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.0017	0.00383	CbGpPWpGaD
Fludrocortisone—Oedema—Capecitabine—esophageal cancer	0.0017	0.00498	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cisplatin—esophageal cancer	0.0017	0.00498	CcSEcCtD
Fludrocortisone—Testosterone—CYP1B1—esophageal cancer	0.0017	0.0302	CrCbGaD
Fludrocortisone—Infection—Capecitabine—esophageal cancer	0.00169	0.00495	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—esophageal cancer	0.00168	0.00379	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CREBBP—esophageal cancer	0.00168	0.00378	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RB1—esophageal cancer	0.00168	0.00377	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00167	0.00374	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00166	0.00374	CbGpPWpGaD
Fludrocortisone—Asthenia—Cisplatin—esophageal cancer	0.00166	0.00485	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.00165	0.00371	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Capecitabine—esophageal cancer	0.00164	0.00482	CcSEcCtD
Fludrocortisone—Dexamethasone—CYP1B1—esophageal cancer	0.00164	0.0292	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—esophageal cancer	0.00161	0.00361	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.00156	0.00351	CbGpPWpGaD
Fludrocortisone—Erythema—Methotrexate—esophageal cancer	0.00155	0.00455	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00155	0.00454	CcSEcCtD
Fludrocortisone—Insomnia—Capecitabine—esophageal cancer	0.00154	0.00451	CcSEcCtD
Fludrocortisone—Megestrol acetate—ABCB1—esophageal cancer	0.00153	0.0272	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NR1I2—esophageal cancer	0.00149	0.00335	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SMAD4—esophageal cancer	0.00146	0.00329	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00144	0.00323	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00141	0.00317	CbGpPWpGaD
Fludrocortisone—Vertigo—Methotrexate—esophageal cancer	0.00139	0.00408	CcSEcCtD
Fludrocortisone—Progesterone—CYP2A6—esophageal cancer	0.00138	0.0246	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00138	0.0031	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.00137	0.00307	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.00137	0.00307	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—esophageal cancer	0.00136	0.00307	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—esophageal cancer	0.00136	0.00305	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00136	0.00305	CbGpPWpGaD
Fludrocortisone—Urticaria—Capecitabine—esophageal cancer	0.00135	0.00396	CcSEcCtD
Fludrocortisone—Convulsion—Methotrexate—esophageal cancer	0.00134	0.00394	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—esophageal cancer	0.00132	0.00387	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.00132	0.00296	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00132	0.00296	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.0013	0.00292	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.00129	0.00291	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCC2—esophageal cancer	0.00128	0.0228	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—HIST1H2BM—esophageal cancer	0.00128	0.00287	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—EP300—esophageal cancer	0.00128	0.00287	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Methotrexate—esophageal cancer	0.00127	0.00371	CcSEcCtD
Fludrocortisone—Dexamethasone—CYP2A6—esophageal cancer	0.00126	0.0225	CrCbGaD
Fludrocortisone—Infection—Methotrexate—esophageal cancer	0.00126	0.00369	CcSEcCtD
Fludrocortisone—Hypersensitivity—Capecitabine—esophageal cancer	0.00125	0.00367	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—esophageal cancer	0.00125	0.00281	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—esophageal cancer	0.00125	0.0028	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP19A1—esophageal cancer	0.00124	0.0222	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.00124	0.00278	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00122	0.00359	CcSEcCtD
Fludrocortisone—Asthenia—Capecitabine—esophageal cancer	0.00122	0.00358	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—esophageal cancer	0.0012	0.00271	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP19A1—esophageal cancer	0.0012	0.0214	CrCbGaD
Fludrocortisone—Methylprednisolone—ABCB1—esophageal cancer	0.00117	0.0209	CrCbGaD
Fludrocortisone—Triamcinolone—PTGS2—esophageal cancer	0.00116	0.0207	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—esophageal cancer	0.00115	0.0026	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00115	0.00338	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—esophageal cancer	0.00115	0.00258	CbGpPWpGaD
Fludrocortisone—Insomnia—Methotrexate—esophageal cancer	0.00115	0.00336	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—esophageal cancer	0.00114	0.00257	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.00111	0.00249	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.0011	0.00247	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00109	0.00245	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—esophageal cancer	0.00109	0.00245	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.00108	0.00243	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.00108	0.00242	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.00107	0.00242	CbGpPWpGaD
Fludrocortisone—Headache—Capecitabine—esophageal cancer	0.00107	0.00312	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—esophageal cancer	0.00105	0.00237	CbGpPWpGaD
Fludrocortisone—Urticaria—Methotrexate—esophageal cancer	0.00101	0.00295	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000998	0.00224	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PSME2—esophageal cancer	0.000992	0.00223	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PSME1—esophageal cancer	0.000992	0.00223	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000985	0.00222	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000978	0.0022	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—esophageal cancer	0.000977	0.0022	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	0.000976	0.00219	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—esophageal cancer	0.000952	0.0169	CrCbGaD
Fludrocortisone—Spironolactone—ABCB1—esophageal cancer	0.000951	0.0169	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000951	0.00214	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—RB1—esophageal cancer	0.00094	0.00211	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000938	0.00211	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH3—esophageal cancer	0.000936	0.0021	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Methotrexate—esophageal cancer	0.000933	0.00273	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	0.000929	0.00209	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—esophageal cancer	0.000918	0.00206	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000918	0.00206	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000914	0.00205	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SMG6—esophageal cancer	0.000912	0.00205	CbGpPWpGaD
Fludrocortisone—Asthenia—Methotrexate—esophageal cancer	0.000908	0.00266	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000902	0.00203	CbGpPWpGaD
Fludrocortisone—Prednisone—ABCB1—esophageal cancer	0.000896	0.016	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH2—esophageal cancer	0.000839	0.00189	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—esophageal cancer	0.000826	0.0147	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000817	0.00184	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000816	0.00183	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000815	0.00183	CbGpPWpGaD
Fludrocortisone—Betamethasone—ABCB1—esophageal cancer	0.00081	0.0144	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000809	0.00182	CbGpPWpGaD
Fludrocortisone—Headache—Methotrexate—esophageal cancer	0.000793	0.00232	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000788	0.00177	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000765	0.00172	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—esophageal cancer	0.000754	0.0017	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000751	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000748	0.00168	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000732	0.00164	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SMAD4—esophageal cancer	0.000705	0.00158	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SMG6—esophageal cancer	0.000692	0.00156	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR1I2—esophageal cancer	0.000691	0.00155	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000684	0.00154	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000679	0.00153	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000676	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—esophageal cancer	0.000675	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	0.000664	0.00149	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000654	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000654	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.00064	0.00144	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—esophageal cancer	0.000632	0.0112	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000622	0.0014	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000614	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HIST1H2BM—esophageal cancer	0.000593	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	0.00058	0.00131	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000555	0.00125	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—esophageal cancer	0.000554	0.00986	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000542	0.00122	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.000537	0.00121	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.00053	0.00119	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NR1I2—esophageal cancer	0.000524	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—esophageal cancer	0.000519	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000515	0.00116	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—esophageal cancer	0.000515	0.00916	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000501	0.00113	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—esophageal cancer	0.000487	0.00866	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—CREBBP—esophageal cancer	0.000471	0.00106	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—esophageal cancer	0.000471	0.00838	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00046	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSME2—esophageal cancer	0.00046	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSME1—esophageal cancer	0.00046	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000454	0.00102	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	0.00045	0.00101	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000445	0.001	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH3—esophageal cancer	0.000434	0.000976	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH2—esophageal cancer	0.000389	0.000875	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.00038	0.000854	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSME1—esophageal cancer	0.000349	0.000785	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSME2—esophageal cancer	0.000349	0.000785	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000344	0.000774	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	0.000329	0.00074	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SMAD4—esophageal cancer	0.000327	0.000735	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	0.000295	0.000664	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—esophageal cancer	0.000279	0.000628	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—esophageal cancer	0.000269	0.000606	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SMAD4—esophageal cancer	0.000248	0.000558	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—esophageal cancer	0.000241	0.000542	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CREBBP—esophageal cancer	0.000219	0.000491	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	0.000204	0.000459	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	0.000183	0.000411	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CREBBP—esophageal cancer	0.000166	0.000373	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—esophageal cancer	0.00013	0.000292	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—esophageal cancer	9.84e-05	0.000221	CbGpPWpGaD
